Covid Usa, Fauci: “Doses to poor countries, it’s right to vaccinate children”

A new pandemic wave of Covid “depends a lot on the degree of success we will achieve with vaccinations. And not just with the initial stage. We begin to observe that immunity is waning. In countries like Israel and then in Great Britain and now in the USA and South Africa, where many people were vaccinated six months ago, and beyond, with the MRNA vaccines and two months ago with Johnson & Johnson, the third dose should be used, in one case, and the second in the other. For those over 18 years old. Unfortunately, globally, there is a very small percentage of vaccinated people, especially in low-income countries. That is why the US and developed nations should take responsibility for sending enough doses to those places. Otherwise the virus will continue to circulate and it will be difficult to be right. Vaccination, therefore, is the answer “. Anthony Fauci said this in an interview with the Press, in which the immunologist and adviser to US President Biden argues that thanks to the fact that “we have already started the ‘booster program’, with 33 million people involved, it is clear that the third dose is as safe as the second and it is important to emphasize how effective it is: if you study the data, it can be seen that it reduces the possibility of being infected and hospitalized by many times and at the same time increases immunity compared to contagion by 10 times and the risk of being affected by the most severe forms of the disease up to 20 times. It is therefore extremely effective in optimizing protection ”. Regarding the decision to administer the third dose after five, six or nine months, Fauci states that “it is a very empirical situation, in many respects. The recommendation in the US is six months or more with the mRna vaccine and two or more months with the Johnson & Johnson. It depends on the countries. In Israel, for example, the threshold of five months or more has been set. Ultimately there isn’t a big difference. We don’t know if we’ll have to get a dose of the vaccine every year. I hope that the third will generate a much longer degree of protection duration than that guaranteed by the two doses. But we won’t be able to know until we vaccinate enough people and follow them over time. It is possible that no further doses will be needed for a year, but it is also possible that after six or nine months we will have to undergo a new dose. We don’t know the answer, but we will find out ”. As for the administration of the vaccine in pediatric age, Fauci declares that “we have carried out clinical trials with children between five and 11 years old with the reduced dose of Pfizer. It is one third of the standard, 10 micrograms. We have observed that it is safe, has no adverse effects, and is 91% effective in preventing disease. For this reason, regulatory agencies recommend that all children be vaccinated. Obligation – he adds – is a delicate issue. It is important to underline that, although it is not pleasant to make mandatory what people believe they should not do independently, it is necessary to achieve a balance: only in this way can we protect ourselves from the consequences of a large number of people who do not vaccinate. And that is why, in the US, we have pushed for stringent rules in business and universities. Also, anyone who works for the federal government must get vaccinated if they want to keep their jobs. We would prefer that people get vaccinated without constraints, but this does not seem to happen: if an adequate proportion of vaccinated people are not reached, not only the unvaccinated are endangered, but, by increasing the flow of contagion, the vaccinated themselves are threatened, given that no vaccine is 100% effective “. Monoclonal antibodies for those who cannot be vaccinated, according to the immunologist, “can prevent infection in those who demonstrate that they do not have a good response to the vaccine. But the importance of the vaccine itself must never be forgotten. While antiretroviral drugs represent a turning point for anti-Covid therapies: “the Merck drug reduces the risk of hospitalization and death by 50%, if administered in the first three to five days of the infection. In the case of the Pfizer drug, it rises to 89%. Although authorization has not yet been granted, we hope that these antiretrovirals will soon be available ”.